Search

everythinglearnresearchcommunity

for

Search:↓

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Spironolactone did not make hair thinner in women with excess hair growth.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

No definitive link between finasteride and male breast cancer, but further research is needed.

Spironolactone plus finasteride works better for treating hirsutism.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

Finasteride use may increase the risk of male breast cancer.